J Biol Chem. 2010 Oct 13. [Epub ahead of print]
Ma D, Li S, Lucas EK, Cowell RM, Lin JD.
Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan;
These studies have demonstrated a physiological role for neuronal PGC-1α in the control of energy balance and strongly suggest that neuronal PGC-1α exerts profound effects on the neural circuitry that governs systemic energy balance.
FULL TEXT PDF
Remark: Interesting conclusions about the action of PGC1-alpha in the neurons, I would like to emphasize that the action of PGC1-a is greatly diminished in the FA.
Sunday, October 31, 2010
Friday, October 29, 2010
Structural; Mechanistic and Coordination Chemistry of Relevance to the Biosynthesis of Iron-Sulfur and Related Iron Cofactors
Coordination Chemistry Reviews, doi:10.1016/j.ccr.2010.10.016
Structural; Mechanistic and Coordination Chemistry of Relevance to the Biosynthesis of Iron-Sulfur and Related Iron Cofactors
Wenbin Qi (a) and J.A. Cowan (a,b)
a Ohio State Biochemistry Program, The Ohio State University
b Department of Chemistry, The Ohio State University
Available online 28 October 2010.
Structural; Mechanistic and Coordination Chemistry of Relevance to the Biosynthesis of Iron-Sulfur and Related Iron Cofactors
Wenbin Qi (a) and J.A. Cowan (a,b)
a Ohio State Biochemistry Program, The Ohio State University
b Department of Chemistry, The Ohio State University
Available online 28 October 2010.
Patent application title: FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES
Inventors: William D. Shrader Viktoria Kheifets Guy M. MILLER
Publication date: 10/28/2010
.../...
14. The method according to claim 6, wherein the ocular symptoms are associated with inherited mitochondrial diseases; Chronic Progressive External Opthalmoplegia (CPEO); Spinocerebellar ataxia (SCA), also called Machado-Joseph disease; Leigh's Syndrome; Friedreich's ataxia (FRDA); Mitochondrial Myopathy, ....
.../...
Publication date: 10/28/2010
.../...
14. The method according to claim 6, wherein the ocular symptoms are associated with inherited mitochondrial diseases; Chronic Progressive External Opthalmoplegia (CPEO); Spinocerebellar ataxia (SCA), also called Machado-Joseph disease; Leigh's Syndrome; Friedreich's ataxia (FRDA); Mitochondrial Myopathy, ....
.../...
Thursday, October 28, 2010
Research offers clues to mechanisms behind childhood-onset disorder, Friedreich's ataxia
Wayne State University, Public Relations, October 28, 2010.
Wayne State University researcher reviews link between frataxin and iron-sulfur clusters
DETROIT - Friedreich's ataxia is a childhood-onset disorder that causes progressive sensory and muscle loss. The molecular mechanisms and processes behind the incurable disorder are still in question, but a Wayne State University researcher is getting closer to the answer.
Timothy L. Stemmler, Ph.D., associate professor of biochemistry and molecular biology in WSU's School of Medicine, has studied the causality of Friedriech's ataxia......
Read more
Wayne State University researcher reviews link between frataxin and iron-sulfur clusters
DETROIT - Friedreich's ataxia is a childhood-onset disorder that causes progressive sensory and muscle loss. The molecular mechanisms and processes behind the incurable disorder are still in question, but a Wayne State University researcher is getting closer to the answer.
Timothy L. Stemmler, Ph.D., associate professor of biochemistry and molecular biology in WSU's School of Medicine, has studied the causality of Friedriech's ataxia......
Read more
Wednesday, October 27, 2010
Exploration of transitional life events in individuals with Friedreich ataxia: Implications for genetic counseling
Behavioral and Brain Functions 2010, 6:65doi:10.1186/1744-9081-6-65
Published: 27 October 2010
V Brook White1*, Jennifer R Leib 2, Jennifer M Farmer3, Barbara B Biesecker4
1Clinical Genetics, Carolinas Medical Center, PO Box 32861, Charlotte, NC 28232-
2861, USA
2HealthFutures, Washington, DC, USA
3Friedreich’s Ataxia Research Alliance, Exton, PA, USA
4National Human Genome Research Institute, National Institutes of Health,
Bethesda, MD, USA
OPEN ACCESS
Background
Human development is a process of change, adaptation and growth. Throughout this process, transitional events mark important points in time when one's life course is significantly altered. This study captures transitional life events brought about or altered by Friedreich ataxia, a progressive chronic illness leading to disability, and the impact of these events on an affected individual's life course.
Methods
Forty-two adults with Friedreich ataxia (18-65y) were interviewed regarding their perceptions of transitional life events. Data from the interviews were coded and analyzed thematically using an iterative process.
Results
Identified transitions were either a direct outcome of Friedreich ataxia, or a developmental event altered by having the condition. Specifically, an awareness of symptoms, fear of falling and changes in mobility status were the most salient themes from the experience of living with Friedreich ataxia. Developmental events primarily influenced by the condition were one's relationships and life's work.
Conclusions
Friedreich ataxia increased the complexity and magnitude of transitional events for study participants. Transitional events commonly represented significant loss and presented challenges to self-esteem and identity. Findings from this study help alert professionals of potentially challenging times in patients' lives, which are influenced by chronic illness or disability. Implications for developmental counseling approaches are suggested for genetic counseling.
FULL TEXT PDF
Published: 27 October 2010
V Brook White1*, Jennifer R Leib 2, Jennifer M Farmer3, Barbara B Biesecker4
1Clinical Genetics, Carolinas Medical Center, PO Box 32861, Charlotte, NC 28232-
2861, USA
2HealthFutures, Washington, DC, USA
3Friedreich’s Ataxia Research Alliance, Exton, PA, USA
4National Human Genome Research Institute, National Institutes of Health,
Bethesda, MD, USA
OPEN ACCESS
Background
Human development is a process of change, adaptation and growth. Throughout this process, transitional events mark important points in time when one's life course is significantly altered. This study captures transitional life events brought about or altered by Friedreich ataxia, a progressive chronic illness leading to disability, and the impact of these events on an affected individual's life course.
Methods
Forty-two adults with Friedreich ataxia (18-65y) were interviewed regarding their perceptions of transitional life events. Data from the interviews were coded and analyzed thematically using an iterative process.
Results
Identified transitions were either a direct outcome of Friedreich ataxia, or a developmental event altered by having the condition. Specifically, an awareness of symptoms, fear of falling and changes in mobility status were the most salient themes from the experience of living with Friedreich ataxia. Developmental events primarily influenced by the condition were one's relationships and life's work.
Conclusions
Friedreich ataxia increased the complexity and magnitude of transitional events for study participants. Transitional events commonly represented significant loss and presented challenges to self-esteem and identity. Findings from this study help alert professionals of potentially challenging times in patients' lives, which are influenced by chronic illness or disability. Implications for developmental counseling approaches are suggested for genetic counseling.
FULL TEXT PDF
Tuesday, October 26, 2010
Research on epigenetic regulation of the CNS
Research on epigenetic regulation of the CNS is a field that is currently being studied for its implications in neuronal regulation. The following papers, although are not about FA, are interesting because they show how these advances can be very important to find a cure for the disease.
Focus on epigenetics
Nature Neuroscience 13, 1299 (2010), Published online: 26 October 2010 | doi:10.1038/nn1110-1299
Epigenetic regulation of the neural transcriptome: the meaning of the marks
Dynamic epigenetic regulation in neurons: enzymes, stimuli and signaling pathways
Epigenetic choreographers of neurogenesis in the adult mammalian brain
Nature Neuroscience 13, 1338 - 1344 (2010)
Published online: 26 October 2010 | doi:10.1038/nn.2672
Focus on epigenetics
Nature Neuroscience 13, 1299 (2010), Published online: 26 October 2010 | doi:10.1038/nn1110-1299
Epigenetic regulation of the neural transcriptome: the meaning of the marks
Nature Neuroscience 13, 1313 - 1318 (2010), Published online: 26 October 2010 | doi:10.1038/nn1110-1313
Nature Neuroscience 13, 1330 - 1337 (2010), Published online: 26 October 2010 | doi:10.1038/nn.2671
Nature Neuroscience 13, 1338 - 1344 (2010)
Published online: 26 October 2010 | doi:10.1038/nn.2672
The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
Molecules. 2010 Oct 20;15(10):7266-91.
Kyeong-Ah Jung and Mi-Kyoung Kwak * email
College of Pharmacy, Yeungnam University, Gyeongsan, Gyeongsangbuk-do 712-749, Korea
OPEN ACCESS
Abstract:
Oxidative stress causes damage to multiple cellular components such as DNA, proteins, and lipids, and is implicated in various human diseases including cancer, neurodegeneration, inflammatory diseases, and aging. In response to oxidative attack, cells have developed an antioxidant defense system to maintain cellular redox homeostasis and to protect cells from damage. The thiol-containing small molecules (e.g. glutathione), reactive oxygen species-inactivating enzymes (e.g. glutathione peroxidase), and phase 2 detoxifying enzymes (e.g. NAD(P)H: quinine oxidoreductase 1 and glutathione-S-transferases) are members of this antioxidant system. NF-E2-related factor 2 (Nrf2) is a CNC-bZIP transcription factor which regulates the basal and inducible expression of a wide array of antioxidant genes. Following dissociation from the cytosolic protein Keap1, a scaffolding protein which binds Nrf2 and Cul3 ubiquitin ligase for proteasome degradation, Nrf2 rapidly accumulates in the nucleus and transactivates the antioxidant response element in the promoter region of many antioxidant genes. The critical role of Nrf2 has been demonstrated by various animal studies showing that mice with a targeted disruption of the nrf2 gene are prone to develop lesions in response to environmental toxicants/carcinogens, drugs, and inflammatory insults. In this review, we discuss the role of the Nrf2 system, with particular focus on Nrf2-controlled target genes and the potential pleiotropic effects of Nrf2 activation of indirect antioxidants.
Keywords: indirect antioxidants; oxidative stress; Nrf2; Keap1
FULL TEXT PDF
Kyeong-Ah Jung and Mi-Kyoung Kwak * email
College of Pharmacy, Yeungnam University, Gyeongsan, Gyeongsangbuk-do 712-749, Korea
OPEN ACCESS
Abstract:
Oxidative stress causes damage to multiple cellular components such as DNA, proteins, and lipids, and is implicated in various human diseases including cancer, neurodegeneration, inflammatory diseases, and aging. In response to oxidative attack, cells have developed an antioxidant defense system to maintain cellular redox homeostasis and to protect cells from damage. The thiol-containing small molecules (e.g. glutathione), reactive oxygen species-inactivating enzymes (e.g. glutathione peroxidase), and phase 2 detoxifying enzymes (e.g. NAD(P)H: quinine oxidoreductase 1 and glutathione-S-transferases) are members of this antioxidant system. NF-E2-related factor 2 (Nrf2) is a CNC-bZIP transcription factor which regulates the basal and inducible expression of a wide array of antioxidant genes. Following dissociation from the cytosolic protein Keap1, a scaffolding protein which binds Nrf2 and Cul3 ubiquitin ligase for proteasome degradation, Nrf2 rapidly accumulates in the nucleus and transactivates the antioxidant response element in the promoter region of many antioxidant genes. The critical role of Nrf2 has been demonstrated by various animal studies showing that mice with a targeted disruption of the nrf2 gene are prone to develop lesions in response to environmental toxicants/carcinogens, drugs, and inflammatory insults. In this review, we discuss the role of the Nrf2 system, with particular focus on Nrf2-controlled target genes and the potential pleiotropic effects of Nrf2 activation of indirect antioxidants.
Keywords: indirect antioxidants; oxidative stress; Nrf2; Keap1
FULL TEXT PDF
Slowing of axonal regeneration is correlated with increased axonal viscosity during aging
BMC Neuroscience 2010, 11:140doi:10.1186/1471-2202-11-140, Published: 25 October 2010
Phillip L Lamoureux, Matthew R O'Toole, Steven R Heidemann and Kyle E Miller
OPEN ACCESS
Conclusions
Taken together, our results suggest decreasing axonal stiffness may be part of an effective strategy to accelerate the regeneration of axons in the adult peripheral nervous system.
FULL TEXT PDF
Phillip L Lamoureux, Matthew R O'Toole, Steven R Heidemann and Kyle E Miller
OPEN ACCESS
Conclusions
Taken together, our results suggest decreasing axonal stiffness may be part of an effective strategy to accelerate the regeneration of axons in the adult peripheral nervous system.
FULL TEXT PDF
Sunday, October 24, 2010
Expression, Purification, and Characterization of an Iron Chaperon Protein CyaY from Acidithiobacillus ferrooxidans
Current Microbiology,DOI: 10.1007/s00284-010-9775-2
Chenbing Ai, Hongyu Mo, Qian Chen, Yuandong Liu, Lin Tang, Juan Du and Jia Zeng
Keywords: CyaY, bacterial homolog of frataxin, iron–sulfur clusters, Acidithiobacillus ferrooxidans, Escherichia coli, affinity chromatography, ferric iron, iron donor, scaffold protein IscU, IscS, l-cysteine.
Full text PDF
Chenbing Ai, Hongyu Mo, Qian Chen, Yuandong Liu, Lin Tang, Juan Du and Jia Zeng
Keywords: CyaY, bacterial homolog of frataxin, iron–sulfur clusters, Acidithiobacillus ferrooxidans, Escherichia coli, affinity chromatography, ferric iron, iron donor, scaffold protein IscU, IscS, l-cysteine.
Full text PDF
Genetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy
Conrad P. Hodgkinson, José A. Gomez, Maria Mirotsou, Victor J. Dzau. Human Gene Therapy. -Not available-, ahead of print. doi:10.1089/hum.2010.165.
Keywords: stem cells, tissue regeneration, bone marrow, therapeutic potential, cardiovascular injury, kidney failure, cancer, neurological and bone disorders. low survival, engraftment, inefficiencies in differentiating into fully functional tissues, genetic engineering, mesenchymal stem cells, genetic modifications.
Keywords: stem cells, tissue regeneration, bone marrow, therapeutic potential, cardiovascular injury, kidney failure, cancer, neurological and bone disorders. low survival, engraftment, inefficiencies in differentiating into fully functional tissues, genetic engineering, mesenchymal stem cells, genetic modifications.
Friday, October 22, 2010
Dynamics of Protein Damage in Yeast Frataxin Mutant Exposed to Oxidative Stress.
OMICS. 2010 Oct 20. [Epub ahead of print]
Kim JH, Sedlak M, Gao Q, Riley CP, Regnier FE, Adamec J.
Bindley Bioscience Center at Discovery Park, Purdue University , West Lafayette, Indiana.
Keywords: Oxidative stress, protein carbonylation, aging, neurodegenerative disorders, diabetes, cancer, biomarkers, energy metabolism, peroxiredoxin (TSA1), thioredoxin II (TRX2).
Kim JH, Sedlak M, Gao Q, Riley CP, Regnier FE, Adamec J.
Bindley Bioscience Center at Discovery Park, Purdue University , West Lafayette, Indiana.
Keywords: Oxidative stress, protein carbonylation, aging, neurodegenerative disorders, diabetes, cancer, biomarkers, energy metabolism, peroxiredoxin (TSA1), thioredoxin II (TRX2).
Thursday, October 21, 2010
Frataxin is an important regulator of iron metabolism
MRC, National Institute for Medical Research, 20 October 2010
Brief summary of the article by Dr. Annalisa Pastore, explaining their research in words more simple and comprehensible to all
Brief summary of the article by Dr. Annalisa Pastore, explaining their research in words more simple and comprehensible to all
Frataxin depletion in yeast triggers upregulation of iron transport systems before affecting iron-sulfur enzyme activities.
J Biol Chem. 2010 Oct 18. [Epub ahead of print]
Moreno-Cermeno A, Obis E, Belli G, Cabiscol E, Ros J, Tamarit J.
University of Lleida, Spain.
Keywords: frataxin, a mitochondrial protein, iron homeostasis, yeast model, frataxin homolog YFH1, aconitase, secondary events, iron overloading, superoxide dismutase, protein carbonyl formation, manganese, metal ion transporter Smf2.
FULL TEXT PDF
Moreno-Cermeno A, Obis E, Belli G, Cabiscol E, Ros J, Tamarit J.
University of Lleida, Spain.
Keywords: frataxin, a mitochondrial protein, iron homeostasis, yeast model, frataxin homolog YFH1, aconitase, secondary events, iron overloading, superoxide dismutase, protein carbonyl formation, manganese, metal ion transporter Smf2.
FULL TEXT PDF
Wednesday, October 20, 2010
Pharmacokinetic evaluation of idebenone.
Expert Opin Drug Metab Toxicol. 2010 Nov;6(11):1437-44.
Becker C, Bray-French K, Drewe J.
Basel Pharmacoepidemiology Unit, University Hospital Basel, Switzerland.
Conclusions: Idebenone shows dose-proportional pharmacokinetics in healthy subjects in daily doses up to 2250 mg, and was safe and well tolerated at doses up to 2250 mg/day, in clinical studies.
Becker C, Bray-French K, Drewe J.
Basel Pharmacoepidemiology Unit, University Hospital Basel, Switzerland.
Conclusions: Idebenone shows dose-proportional pharmacokinetics in healthy subjects in daily doses up to 2250 mg, and was safe and well tolerated at doses up to 2250 mg/day, in clinical studies.
Pathogenesis of impaired glucose tolerance and diabetes in Friedreich's ataxia: contribution of insulin resistance and pancreatic beta cell dysfunction.
The free library,
Miriam Cnop, MD, PhD, Universite Libre de Bruxelles, Brussels, Belgium
Research summary
Keywords: pancreatic b cells, Friedreich's ataxia, insulin demand.
Miriam Cnop, MD, PhD, Universite Libre de Bruxelles, Brussels, Belgium
Research summary
Keywords: pancreatic b cells, Friedreich's ataxia, insulin demand.
Tuesday, October 19, 2010
Structural bases for the interaction of frataxin with the central components of iron–sulphur cluster assembly
Nature Communications, Volume:1, Article number: 95, DOI: doi:10.1038/ncomms1097
Received 08 June 2010, Accepted 22 September 2010, Published 19 October 2010
National Institute for Medical Research, The Ridgeway, London NW7 1AA, UK.
* Filippo Prischi,
* Clara Iannuzzi,
* Chiara Pastore,
* Salvatore Adinolfi,
* Stephen R. Martin &
* Annalisa Pastore
European Molecular Biology Laboratory, EMBL c/o DESY, Notkestrasse 85, Hamburg D-22603, Germany.
* Petr V. Konarev &
* Dmitri I. Svergun
OPEN ARTICLE
Received 08 June 2010, Accepted 22 September 2010, Published 19 October 2010
National Institute for Medical Research, The Ridgeway, London NW7 1AA, UK.
* Filippo Prischi,
* Clara Iannuzzi,
* Chiara Pastore,
* Salvatore Adinolfi,
* Stephen R. Martin &
* Annalisa Pastore
European Molecular Biology Laboratory, EMBL c/o DESY, Notkestrasse 85, Hamburg D-22603, Germany.
* Petr V. Konarev &
* Dmitri I. Svergun
OPEN ARTICLE
Mitochondrial ROS Generation and Its Regulation: Mechanisms Involved in H2O2 Signaling
Antioxidants & Redox Signaling. Online Ahead of Print: October 18, 2010, doi:10.1089/ars.2010.3363.
Michel Rigoulet, Edgar D. Yoboue, Anne Devin. Université Bordeaux 2, and Institute of Biochemistry and Genetics of the Cell (IBGC) du CNRS, Bordeaux, France.
Keyworsd: Mitochondria, reactive oxygen species, oxidative stress, respiratory chain, dehydrogenases, bc1 complex, complex I, signaling molecules.
Michel Rigoulet, Edgar D. Yoboue, Anne Devin. Université Bordeaux 2, and Institute of Biochemistry and Genetics of the Cell (IBGC) du CNRS, Bordeaux, France.
Keyworsd: Mitochondria, reactive oxygen species, oxidative stress, respiratory chain, dehydrogenases, bc1 complex, complex I, signaling molecules.
Public summary of opinion on orphan designationN-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide for the treatment of Friedreich’s ataxia,
12 October 2010
EMA/COMP/455242/2010
Committee for Orphan Medicinal Products.
On 1 October 2010, orphan designation (EU/3/10/793) was granted by the European Commission to Repligen Europe Limited, Ireland, for N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide for the treatment of Friedreich’s ataxia.
EMA/COMP/455242/2010
Committee for Orphan Medicinal Products.
On 1 October 2010, orphan designation (EU/3/10/793) was granted by the European Commission to Repligen Europe Limited, Ireland, for N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide for the treatment of Friedreich’s ataxia.
Sunday, October 17, 2010
Induced pluripotency: history, mechanisms, and applications
Genes & Dev. 2010. 24: 2239-2263, doi: 10.1101/gad.1963910
Matthias Stadtfeld, Konrad Hochedlinger
(REVIEWS)
OPEN ACCESS
The generation of induced pluripotent stem cells (iPSCs) from somatic cells demonstrated that adult mammalian cells can be reprogrammed to a pluripotent state by the enforced expression of a few embryonic transcription factors.
FULL TEXT PDF
Matthias Stadtfeld, Konrad Hochedlinger
(REVIEWS)
OPEN ACCESS
The generation of induced pluripotent stem cells (iPSCs) from somatic cells demonstrated that adult mammalian cells can be reprogrammed to a pluripotent state by the enforced expression of a few embryonic transcription factors.
FULL TEXT PDF
Thursday, October 14, 2010
In vivo evidence for the iron binding activity of an iron-sulfur cluster assembly protein IscA in Escherichia co
Biochem. J. (2010) Immediate Publication, doi:10.1042/BJ20101507
Wu Wang, Hao Huang, Guoqiang Tan, Fan Si, Min Liu, Aaron P. Landry, Jianxin Lu and Huangen Ding
Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, U.S.A.
"IscU, a proposed iron-sulfur cluster assembly scaffold protein, and CyaY, a bacterial frataxin homolog that has been postulated as an iron donor for the iron-sulfur cluster assembly, fail to bind any iron in E. coli cells under the same experimental conditions"
FULL TEXT PDF
Wu Wang, Hao Huang, Guoqiang Tan, Fan Si, Min Liu, Aaron P. Landry, Jianxin Lu and Huangen Ding
Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, U.S.A.
"IscU, a proposed iron-sulfur cluster assembly scaffold protein, and CyaY, a bacterial frataxin homolog that has been postulated as an iron donor for the iron-sulfur cluster assembly, fail to bind any iron in E. coli cells under the same experimental conditions"
FULL TEXT PDF
Epigenetic modifications and human disease
Nature Biotechnology, Volume:28, Pages:1057–1068,Year published:(2010)
DOI:10.1038/nbt.1685, Published online 13 October 2010
Anna Portela & Manel Esteller
Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
Manel Esteller
Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
Epigenetic modifications in neurodegenerative and neurological diseases (Friedreich's ataxia) , Epigenetic modifications in neurodevelopmental disorder
FULL TEXT
DOI:10.1038/nbt.1685, Published online 13 October 2010
Anna Portela & Manel Esteller
Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
Manel Esteller
Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
Epigenetic modifications in neurodegenerative and neurological diseases (Friedreich's ataxia) , Epigenetic modifications in neurodevelopmental disorder
FULL TEXT
Epigenetic modifications as therapeutic targets
Nature Biotechnology, Volume: 28 ,Pages: 1069–1078,Year published:(2010)
DOI:10.1038/nbt.1678, Published online 13 October 2010
Theresa K Kelly, Daniel D De Carvalho & Peter A Jones Departments of Urology and Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
The paper focus on recent examples in which epigenetic modifications have been used to evaluate disease risk, progression and clinical response. It provide a broad overview of the accomplishments, remaining challenges and unrealized potential of epigenetic therapies in a range of diseases, with a particular emphasis on cancer.
FULL TEXT
DOI:10.1038/nbt.1678, Published online 13 October 2010
Theresa K Kelly, Daniel D De Carvalho & Peter A Jones Departments of Urology and Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
The paper focus on recent examples in which epigenetic modifications have been used to evaluate disease risk, progression and clinical response. It provide a broad overview of the accomplishments, remaining challenges and unrealized potential of epigenetic therapies in a range of diseases, with a particular emphasis on cancer.
FULL TEXT
On the Trail of the Epigenetic Code: Test System on Drosophila Should Provide the Key to Histone Function
ScienceDaily (Oct. 12, 2010) — Test system on Drosophila should provide the key to histone function. The genetic inherited material DNA was long viewed as the sole bearer of hereditary information. The function of its packaging proteins, the histones, was believed to be exclusively structural. Additional genetic information can be stored, however, and passed on to subsequent generations through chemical changes in the DNA or histones. read more
Original paper: A genetic system to assess in vivo the functions of histones and histone modifications in higher eukaryotes
Full text pdf
Original paper: A genetic system to assess in vivo the functions of histones and histone modifications in higher eukaryotes
Full text pdf
Tuesday, October 12, 2010
Kinematic analysis of lingual movements during consonant productions in dysarthric speakers with Friedreich's ataxia: A case-by-case analysis.
Clin Linguist Phon. 2010 Oct 8. [Epub ahead of print]
Folker JE, Murdoch BE, Cahill LM, Delatycki MB, Corben LA, Vogel AP.
School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD, Australia.
Folker JE, Murdoch BE, Cahill LM, Delatycki MB, Corben LA, Vogel AP.
School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD, Australia.
An in Vivo Method for Characterization of Protein Interactions within Sulfur Trafficking Systems of E. coli
J. Proteome Res., Just Accepted Manuscript, DOI: 10.1021/pr100920r
Publication Date (Web): October 11, 2010
Heather May Bolstad and Matthew James Wood
KEYWORDS: iron-sulfur clusters, in vivo method, mass spectrometry, iron-sulfur biogenesis, general tool for the determination of sulfur trafficking mechanisms.
FULL TEXT PDF
Publication Date (Web): October 11, 2010
Heather May Bolstad and Matthew James Wood
KEYWORDS: iron-sulfur clusters, in vivo method, mass spectrometry, iron-sulfur biogenesis, general tool for the determination of sulfur trafficking mechanisms.
FULL TEXT PDF
Dizziness in Orthopaedic Physical Therapy Practice: History and Physical Examination
The Journal of Manual & Manipulative Therapy
Vol. 13 No. 4 (2005), 222 - 251
Paul Vidal, PT, MHSc, DPT, OCS, MTC
Peter Huijbregts, PT, MSc, MHSc, DPT, OCS, MTC, FAAOMPT, FCAMT
Physical therapy (PT) differential diagnosis of patients complaining of dizziness centers on distinguishing those patients who might benefit from sole management by the physical therapist from those patients who require referral for medical-surgical differential diagnosis and (co) management.....
FULL TEXT PDF
Vol. 13 No. 4 (2005), 222 - 251
Paul Vidal, PT, MHSc, DPT, OCS, MTC
Peter Huijbregts, PT, MSc, MHSc, DPT, OCS, MTC, FAAOMPT, FCAMT
Physical therapy (PT) differential diagnosis of patients complaining of dizziness centers on distinguishing those patients who might benefit from sole management by the physical therapist from those patients who require referral for medical-surgical differential diagnosis and (co) management.....
FULL TEXT PDF
Microchip Technology Rapidly Identifies Compounds for Regrowing Nerves in Live Animals
ScienceDaily (Oct. 11, 2010) — Scientists have long sought the ability to regenerate nerve cells, or neurons, which could offer a new way to treat spinal-cord damage as well as neurological diseases such as Alzheimer's or Parkinson's. Many chemicals can regenerate neurons grown in Petri dishes in the lab, but it's difficult and time-consuming to identify those chemicals that work in live animals, which is critical for developing drugs for humans. read more
Friday, October 8, 2010
Evaluation of neuropsychological functions in patients with Friedreich ataxia before and after cognitive therapy
Funct Neurol. 2010 Apr-Jun;25(2):81-5.
Ciancarelli I, Cofini V, Carolei A.
Keywords: Friedreich ataxia (FA, severe disability, cognitive functions, mood disorders, conflicting results, role of cognitive rehabilitation therapy, MMSE, Rey 15-item Memorization Test, Raven's Colored Progressive Matrices, the Phonemic Verbal Fluency Test, the Symbol Digit Modalities Test, Zung scale.
Ciancarelli I, Cofini V, Carolei A.
Keywords: Friedreich ataxia (FA, severe disability, cognitive functions, mood disorders, conflicting results, role of cognitive rehabilitation therapy, MMSE, Rey 15-item Memorization Test, Raven's Colored Progressive Matrices, the Phonemic Verbal Fluency Test, the Symbol Digit Modalities Test, Zung scale.
Wednesday, October 6, 2010
Remarkably Efficient New Method For Generating Human Stem Cells
Medical News Today, Article Date: 02 Oct 2010 - 0:00 PDT
The ability to efficiently generate patient-specific stem cells from differentiated cells and then reliably direct them to form specialized cells (like neurons or muscle) has tremendous therapeutic potential for replacing diseased or damaged tissues... read more
Technology Review, Friday, October 1, 2010
A New Way to Make Stem Cells
Using RNA instead of DNA could avoid the health risks--and the political pitfalls--of stem-cell treatments.
A Harvard researcher has developed a way to make pluripotent stem cells that solves several of the major impediments to using them to treat human diseases. read more...
The ability to efficiently generate patient-specific stem cells from differentiated cells and then reliably direct them to form specialized cells (like neurons or muscle) has tremendous therapeutic potential for replacing diseased or damaged tissues... read more
Technology Review, Friday, October 1, 2010
A New Way to Make Stem Cells
Using RNA instead of DNA could avoid the health risks--and the political pitfalls--of stem-cell treatments.
A Harvard researcher has developed a way to make pluripotent stem cells that solves several of the major impediments to using them to treat human diseases. read more...
Tuesday, October 5, 2010
Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly.
J Biol Chem. 2010 Oct 2. [Epub ahead of print]
Gakh O, Bedekovics T, Duncan SF, Smith DY 4th, Berkholz DS, Isaya G.
Mayo Clinic, United States.
Keywords: frataxin (FXN), Fe-S cluster, FXN mRNA, FXN42-210, FXN81-210, levels of both isoforms are relevant, FXN81-210/FXN42-210 molar ratio, replacement therapies.
Gakh O, Bedekovics T, Duncan SF, Smith DY 4th, Berkholz DS, Isaya G.
Mayo Clinic, United States.
Keywords: frataxin (FXN), Fe-S cluster, FXN mRNA, FXN42-210, FXN81-210, levels of both isoforms are relevant, FXN81-210/FXN42-210 molar ratio, replacement therapies.
Saturday, October 2, 2010
PGC-1 Coactivators in Cardiac Development and Disease
Circulation Research. 2010;107:825-838
doi: 10.1161/CIRCRESAHA.110.223818
Daniel P. Kelly, Guest Editor
Glenn C. Rowe, Aihua Jiang, Zolt Arany
From the Cardiovascular Institute at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.
Key Words: PGC-1 • metabolism • heart failure • mitochondria
doi: 10.1161/CIRCRESAHA.110.223818
Daniel P. Kelly, Guest Editor
Glenn C. Rowe, Aihua Jiang, Zolt Arany
From the Cardiovascular Institute at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.
Key Words: PGC-1 • metabolism • heart failure • mitochondria
Subscribe to:
Posts (Atom)